Brief: Hofseth Biocare Q3 EBITDA Loss Widens To NOK 23.2 Mln
Oct 30 (Reuters) - Hofseth Biocare ASA HOFS.OL :
* REG-HOFSETH BIOCARE ASA: THIRD QUARTER 2020 FINANCIAL
REPORT
* Q3 GROSS OPERATING REVENUE NOK 7.6 MILLION VERSUS NOK 29.2
MILLION YEAR AGO
* Q3 EBITDA LOSS NOK 23.2 MILLION VERSUS LOSS NOK 7.6
MILLION YEAR
AGO
Source text for Eikon: ID:nGNE9jDdT0
Further company coverage: HOFS.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering